Avidity Partners Invests $9M in Aktis Oncology episode artwork

EPISODE · May 13, 2026 · 1 MIN

Avidity Partners Invests $9M in Aktis Oncology

from The Daily News Now! Business

Avidity Partners Management invests $9.1M in Aktis Oncology, marking a new bet for the biotech fund. Aktis develops targeted radiopharmaceuticals for cancer treatment, with lead drugs AKY-1189 and AKY-2519. The investment, valued at $8.79M, represents approximately 2% of Aviditys reportable assets. Aktiss market cap reached $1B, with TTM revenue of $6.5M and a net loss of $63.73M. This move by Avidity signals confidence in Aktiss pipeline, making it an oncology investment to watch. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/cca89b8188e476fe

NOW PLAYING

Avidity Partners Invests $9M in Aktis Oncology

0:00 1:34

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 1 minute long.

When was this The Daily News Now! Business episode published?

This episode was published on May 13, 2026.

What is this episode about?

Avidity Partners Management invests $9.1M in Aktis Oncology, marking a new bet for the biotech fund. Aktis develops targeted radiopharmaceuticals for cancer treatment, with lead drugs AKY-1189 and AKY-2519. The investment, valued at $8.79M,...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!